Esbm assignmEnt

Entrepreneur Traits and Qualities INTRODUCTION: Dilip Shanghvi: The Drug Maker with a Midas touch Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries Limited. He was born on 1st Oct 1955 in Mumbai, India. He holds a Bachelor of Commerce degree from the University of Calcutta. He is alumni of J. J. Ajmera High School and Bhawanipur Education Society College, where from he did his schooling and graduation, respectively. COMPANYS INTRODUCTION: Sun Pharma was founded in 1983 and it is currently the second-largest drug maker in India. With the surge of 50% in the wealth of around USD 4.7 billion, Shanghvi is now the third richest Indian. With March 2013 revenues of about Rs.11, 240 crores, of which over 70% is from international markets. Sun Pharma has the largest US presence amongst all Indian generic companies, and is the 5th largest Indian company in the US. Sun Pharma is the fastest growing, most profitable and highest valued pharmaceutical company in India. Sun Pharma, as a start up, had first year sales of USD 0.02 million in 1983. Family Background: He was inducted into his fathers small pharma trade business when he was 18 and a commerce undergraduate at Calcutta University. He borrowed his friends equipment and Rs.10, 000 from his father and Sun Pharmaceuticals officially opened for Business. More than 70% of his companys revenues come from India. A Drug trader turned to Drug Manufactures, such challenges are not new for Dilip Shanghvi, a Gujarati who started his career in Kolkata and moved to Mumbai to set up a Drug firm in 1983. He is married to Karishma Shanghvi, a homemaker and having two children Aalok and Raksha.

TRAITS of Dilip Shanghvi 1) Risk taker: He decided to take a plunge in pharmaceutical industry; it was a big risk anyway. He had decided to manufacture drugs that only a handful of multinational companies made. 2) Innovator: The team is in innovation of products that are in development for treatment of cancer and certain ophthalmological conditions. 3) Leader: He won the business leadership award of the year in 2012 and 2010. He has employees situated in different parts of the world and motivating them to work together and efficiently. 4) Motivator: He has been a great motivator by involving with employees in all parts of the world and do not differentiate in employees. 5) Optimistic: He is very optimistic about the growth of pharmaceutical industry. He says drug industry is growing at a very fast pace and the reasons for this growth are natural and understandable. 6) Prepared for Crisis: He follows a mantra in his life that you cannot predict when there will be crisis, but you should anticipate and be prepared to cope with it when it strikes. OBSTACLES: 2008-09 was a challenging year. In many ways. Every single economy of the world witnessed an economic downturn fuelled by the global liquidity crisis. The speed and the impact were in itself, daunting. Within the changes and corrections in the global systems is a ray of hope, not just for the world but for pharmaceutical companies like ours, as the focus on affordable health care intensifies. Coincidentally, we too went through one of our more challenging years since we started business. Though new situations have been part of our business ever since we started to build it in 1983 and grew it to a Rs. 42,723 million business by 2008-09, the circumstances that we faced in 2008-09 were very different in magnitude and character. Our 76% USA subsidiary Caraco received a Form 483 on inspection conducted by US FDA at its Detroit manufacturing facilities. This was followed by a warning letter on quality and non-conformance with SOP for the same facility.

SUGGESTION: Majority of the doctors and pharmacist were able to recall only limited drugs, while sun Pharma comes with 25-30 drugs every year, so it needs to promote their brands more.